483 Response US Vascular Apr 2017

James Hildreth FDA$119.00 - Available Now

FDA investigators audited the US Vascular - Beaverton, OR, United States facility and issued inspectional observation (via FDA 483) on 24 Apr 2017.

Product details

  • Category:
  • Inspection end: 24 Apr 2017
  • Location: Beaverton, United States
  • FEI: 3010089756
Add To Cart